Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors), PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endocrinology and Metabolic Disease | Discovery | - | 08 Nov 2024 | |
Immune System Diseases | Discovery | - | 08 Nov 2024 | |
Infectious Diseases | Discovery | - | 08 Nov 2024 | |
Inflammation | Discovery | - | 08 Nov 2024 | |
Myocarditis | Discovery | - | 08 Nov 2024 | |
Neoplasms | Discovery | - | 08 Nov 2024 | |
Neurodermatitis | Discovery | - | 08 Nov 2024 | |
Nonalcoholic Steatohepatitis | Discovery | - | 08 Nov 2024 | |
Respiratory Diseases | Discovery | - | 08 Nov 2024 |